The Department of Justice has accused two drug industry executives of fixing prices of generic drugs.
Bloomberg is reporting that the former president and former CEO of Heritage Pharmaceuticals were both charged Monday.
In November, Bloomberg reported that Federal prosecutors may start bringing down charges regarding price fixing as part of a larger investigation into generic drugmakers. EpiPen-maker Mylan and Teva Pharmaceuticals are among the other companies under investigation.
This story is developing.
NOW WATCH: Money & Markets videos
Business Insider Emails & Alerts
Site highlights each day to your inbox.